TRIMESUL C.M., 40 mg/ml + 200 mg/ml, soluzione iniettabile per bovini, suini, equini, cani, gatti
TRIMESUL C.M., 40 mg/ml + 200 mg/ml, soluzione iniettabile per bovini, suini, equini, cani, gatti
Authorised
- Sulfadiazine
- Trimethoprim
Product identification
Medicine name:
TRIMESUL C.M., 40 mg/ml + 200 mg/ml, soluzione iniettabile per bovini, suini, equini, cani, gatti
Active substance:
- Sulfadiazine
- Trimethoprim
Target species:
-
Cattle
-
Pig
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Sulfadiazine200.00/milligram(s)1.00millilitre(s)
-
Trimethoprim40.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Milk4day
-
Meat and offal14day
-
-
Pig
-
Meat and offal14day
-
-
-
Intravenous use
-
Cattle
-
Milk4day
-
Meat and offal14day
-
-
Pig
-
Meat and offal14day
-
-
Horse
-
Meat and offal14dayUso non autorizzato in equidi che producono latte per il consumo umano
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01EW10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
- Vetem S.p.A.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 6/06/2023
Updated on: 8/06/2023